A panel of 114 blood samples from chronic chagasic patients and nonchagasic patients was screened for Trypanosoma cruzi by xenodiagnostic, serologic, and polymerase chain reaction (PCR) amplification tests. Blood samples were preserved in a guanidine-EDTA buffer, and total blood DNA was isolated after chemical nuclease cleavage with 1,10-phenanthroline-copper ion and used as a template for PCR amplification of the conserved and variable regions of T. cruzi minicircle molecules. The PCR products were screened by Southern blot hybridization with a digoxigenin-labeled oligonucleotide probe specific for the conserved region of the minicircle. The method showed a sensitivity of 100%o compared with the serologic test. In addition, all of the serology-positive, xenodiagnosis-negative samples were positive by PCR. This demonstrates that PCR amplification of T. cruzi kinetoplast minicircle DNA could replace xenodiagnosis for evaluation of parasitemia in chronic chagasic patients and could serve as a complement for serologic testing in the screening of blood bank donors.
cnrzi, is transmitted by triatomid bugs. However, human transmission can occur by alternative routes, such as blood transfusion and congenital infection. During the initial, acute phase, direct detection of the parasite in blood smears is possible because of the high levels of parasitemia. In contrast, detection of T. cruzi during the lifelong chronic phase requires biological amplification methods, such as hemoculture and xenodiagnosis, because of the low levels of parasitemia. Xenodiagnosis represents the most sensitive and specific assay for direct detection of T. cruzi in blood of chronic chagasic patients. However, xenodiagnosis yields positive results in only 17 to 70% of serologically positive patients (18) . Serologic tests for diagnosis of chronic Chagas' disease have high sensitivity but lack specificity because of antigenic cross-reactivity with other parasites, such as Leishmania sp. and T. rangeli (12, 17) . In addition,.serologic assays only detect antibodies against the parasite and not the presence of the parasite itself. This is an important consideration when deciding what tests to use to monitor cure rates in patients undergoing drug treatment for Chagas' disease.
We have previously developed a method for the lysis and storage of whole blood specimens at room temperature and a procedure for the isolation of kinetoplast DNA (kDNA) from these blood lysates with subsequent polymerase chain reaction (PCR) amplification of kDNA minicircle sequences (5) . Briefly, the procedure is as follows. Whole blood is stored at room temperature as a lysate in 3 M guanidine HC1-0.1 M EDTA. DNA stored in these guanidine-EDTAblood lysates remains undegraded for 1 month at 37°C. T. cruzi minicircle DNA in the blood lysate is randomly cleaved * Corresponding author.
by using the chemical nuclease 1,10-phenanthroline-copper ion. This procedure liberates minicircle molecules from catenation in networks, thereby distributing them throughout the lysate and allowing a small aliquot of the original lysate to be analyzed for minicircle sequences. We showed that the presence of excess human DNA has no effect on the amplification of parasite minicircle DNA (5, 19) and that kDNA minicircle sequences represent appropriate speciesand strain-specific markers for detection and classification of T. cnzi (4, 19) . The 1.4-kb T. crzi minicircle molecules are organized into four segments, each consisting of a short DNA region with a high level of sequence conservation among all T. cnuzi minicircles and a longer DNA region exhibiting high sequence variability (8) . Primers within the conserved regions were used to PCR amplify the variable regions bracketed between them, generating a 330-bp PCR product (4, 19) . The extensive DNA sequence heterogeneity observed in T. crui minicircle variable regions, both within a strain and between strains, allows the classification of T. cruzi strains into schizodemes (4, 13), which probably represent naturally occurring clones which have been genetically isolated from each other in nature for long periods (20) (21) (22) . This classification could serve as an important epidemiological tool for monitoring of specific parasite strains in nature, as well as for understanding the possible role of parasite genetic diversity in the disease syndrome.
In this study, we utilized the guanidine-EDTA-blood-PCR method described above to analyze a large panel of blood samples from chagasic patients which were also analyzed by conventional serologic methods and xenodiagnosis. Comparison of the results obtained with the three different tests indicated that PCR has 100% sensitivity compared with serologic testing and is more sensitive than xenodiagnosis. of Virgem da Lapa (VL), Minas Gerais, Brazil (see Table 1 ). min on each patient, and the insects' feces were examined microscopically 45 days after feeding for the presence of T.
cnrzi.
Isolation of DNA for PCR. Blood lysates were prepared by mixing equal volumes of blood and GE buffer (6 M guanidine, 0.2 M EDTA, pH 8.0) and then stored at 4°C. Blood specimens from the University of California at Los Angeles (UCLA) blood bank were used as negative controls for the PCR assay. A 5-ml aliquot of each blood lysate sample was processed as described previously (5) . Briefly, 0.5 ml of each of the following solutions was added in the following order: 1 M MgCl2, 200 mM CUSO4, 20 mM phenanthroline, and 7.5% H202. The blood lysates were then incubated at 37°C for 30 min, and the reaction was stopped by addition of 0.5 ml of 58 mM 3-mercaptopropionic acid. After 1,10-phenanthroline-copper ion cleavage of the DNA, a 500-,ul aliquot of each blood lysate was extracted with 100 pl of phenolchloroform (1:1). The supernatants were transferred to a clean tube, and the DNA was precipitated at room temperature by addition of 50 p,l of 3 M sodium acetate and 1 ml of ethanol. The DNA pellets were resuspended in 1 ml of water and washed twice with water in Centricon-100 centrifugal filtration units (Amicon) as described by the manufacturer. The DNA was finally resuspended in 200 ,ul of water. In recent experiments, we have found that the Centricon filtration step can be eliminated by a single extraction of the cleaved blood lysate with a resin (Strataclean resin; Stratagene) which removes most of the protein prior to precipitation of the DNA (data not shown). All of the PCR amplifications reported in this study, however, were performed with Centricon purification.
PCR. A 70-,ul aliquot of the resuspended DNA was PCR amplified by using T. cruzi-specific minicircle primers S35 (5'-AAATAATGTACGGG[T/G]GAGATGCATGA-3') and S36 (5'-GGGTTCGATTGGGGTTGGTGT-3'). The primers were annealed to the four conserved regions of each T. cruzi minicircle molecule (4, 19) . A 330-bp PCR amplification product which encompassed all of the adjacent variable regions and a small portion of the conserved region (approximately 70 bp) was generated. PCR conditions have been described previously (4, 5) . Denaturation, annealing, and elongation steps were performed for a total of 30 cycles, for 1 min each at 94, 60, and 72°C, respectively.
Analysis of 330-bp PCR products. The PCR products were chloroform extracted and ethanol-precipitated, and each TTT-3'), which hybridizes to the conserved region of T.
cruzi minicircle molecules (19 (18) .
PCR. Figure 1 shows an example of products, obtained after PCR amplification of clinical specimens with the S35 and S36 primer set, electrophoresed in an ethidium bromidestained agarose gel. There is some variation from sample to sample in the intensity of the background bands and T. cruzi-specific bands. Figure 2 shows representative hybridization results obtained for the PCR-amplified samples with the digoxigenin-labeled S67 probe. None of the background bands seen in Fig. 1 gave a signal when the Southern blots were hybridized with the S67 probe ( Fig. 2A) . Hybridizations with digoxigenin-labeled probes showed the same level of sensitivity as hybridizations with 32P-labeled probes (data not shown). Identical results were obtained with both types of probes; however, the use of digoxigenin-labeled probes avoids all of the problems and hazards associated with 32P-labeled probes without compromising the results. The 330-bp band is the expected size of T. cruzi PCR-amplified products obtained with the S35 and S36 primer set. The larger PCR products of 660 and 990 bp (Fig. 2) are multiples of the minicircle variable regions and are due to the fourfold repeat structure of the T. cruzi minicircles. The nature of the smaller 180-bp band seen in some samples (Fig. 2) is unknown and is being investigated. However, it is important to note that this 180-bp band is T. cruzi specific since it appeared only when T. cruzi minicircle DNA was present.
Samples from the UCLA blood bank were used as negative controls. Addition of kDNA to several of these control samples prior to amplification indicated that they did not inhibit PCRs. The UCLA blood samples were processed simultaneously with the coded samples from VL to monitor for any cross-contamination problems which may have arisen during the preparation of specimens for PCR. All of these controls proved PCR negative, indicating a lack of contamination in the PCR reagents and during processing of the samples (Fig. 2 and Table 2 ).
It should be noted that the presence or absence of a 330-bp PCR-generated product in the blots is unambiguous compared with negative controls. The only exceptions were samples VL48 and VL50, which showed no 330-bp PCR product but showed the 180-bp T. cruzi-specific PCR prodmatch the signal intensity of the sample lanes. The anomalous (faster) migration of the 330-bp band in the positive control lane is due to differences in salt concentration between diluted positive control and undiluted VL samples. Sample VL46 was serology negative. Samples VL48 and VL50 exhibited only the 180-bp T. cruzi-specific PCR product (arrow). (9, 10, 14) . In the case of chronic Chagas' disease, direct detection of T. cruzi cells in peripheral blood is extremely difficult and direct DNA hybridization methods have proved unsuccessful (3) . We have shown in this study that PCR amplification of minicircle kDNA sequences appears to be an appropriate technique for detection of T. cnuzi in chronic chagasic patients. In addition, we have shown that the guanidine-EDTA lysis reagent is applicable to blood sample collection and storage in the field in a tropical environment.
An alternative approach has recently been reported in which T. cruzi parasite DNA which was detected in serum samples was used for amplification of a 195-bp T. cnrzispecific nuclear repetitive sequence (16 Our results indicate that the kDNA PCR amplification method has 100% sensitivity compared with serologic testing. Furthermore, the PCR method gave a positive result in all of the cases that were serology positive but xenodiagnosis negative. Clearly, xenodiagnosis lacks sensitivity. These results suggest that PCR could replace xenodiagnosis in the direct parasitological evaluation of chronic chagasic patients. Such an evaluation is necessary for monitoring of drug treatment of chronic chagasic patients and cure determination.
The serologic tests for Chagas' disease have very high sensitivity, from 95 to 100%, in the chronic phase of the disease (7, 17) . However, the main problem for blood banks screening for chagasic patients is the variable number of cases reacting around the cutoff level in the present serologic tests (2) ; therefore, a confirmatory test for the presence of T. cruzi parasites in the blood is necessary. The PCR method could serve as the confirmatory test for Chagas' disease in blood banks.
Another advantage of the kDNA PCR amplification method lies in the ability to use the inherent sequence polymorphisms of the amplified minicircle variable regions to classify the parasites as schizodemes or clones (4, 6) . This would allow investigation of the question of a correlation of the clinical syndrome and the parasite schizodeme and would also serve as an important epidemiological tool. This work is in progress for the samples from VL.
The DNA isolation procedure we have developed yields total blood DNA as a template, allowing possible coamplification of human genetic loci, for example, the human major histocompatibility complex, in addition to infectious agentspecific DNA sequences. The development of a PCR multiplex system which allows coamplification of both human and pathogen DNA sequences could further our understanding of the interactions between pathogen and host factors and the role these interactions play in disease development. We thank Elizabeth Wagar for helpful comments on the manuscript.
